Tecan reports strong performance during first half of 2017

Tecan has announced its financial results for the first half of 2017, during which it delivered a significant increase in order entry and strong sales growth.

The company's order entries came to 291.2 million Swiss francs (234.84 million pounds), representing a year-on-year increase of 16.7 percent in local currency terms, while sales advanced by eight percent to 253.3 million Swiss francs.

Particularly strong sales growth was achieved by the company's life sciences business, thanks in part to the integration of SPEware Corporation and the acquisition of Pulssar Technologies, as well as the launch of a new platform development project with DiaSorin.

For the full year, Tecan continues to anticipate group sales growth of more than six percent in local currency terms.

David Martyr, Tecan's chief executive officer, said: "Tecan's sales have developed well, once again, in the current financial year. The strong growth in our end-customer business, the life sciences business, and in the components business – as part of the partnering business – was particularly pleasing."

With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.